{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:18:36Z","timestamp":1781079516280,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008093","name":"Schulich School of Medicine and Dentistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007059","name":"Western University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008958","name":"Lawson Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1053\/j.ajkd.2020.02.446","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T20:28:34Z","timestamp":1587587314000},"page":"311-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants"],"prefix":"10.1053","volume":"76","author":[{"given":"Justin","family":"Ashley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziv","family":"Harel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Battistella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber O.","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil V.","family":"Badve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit X.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tanuseputro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mavrakanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish M.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"46","key":"10.1053\/j.ajkd.2020.02.446_bib1","first-page":"3238","article-title":"Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis","volume":"36","author":"Andreotti","year":"2015","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1053\/j.ajkd.2020.02.446_bib2","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ajkd.2020.02.446_bib3","first-page":"537","article-title":"Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin","volume":"94","author":"Gasse","year":"2005","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1053\/j.ajkd.2020.02.446_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0163-7258(96)00140-4","article-title":"Human P450 metabolism of warfarin","volume":"73","author":"Kaminsky","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1053\/j.ajkd.2020.02.446_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2017.04.027","article-title":"Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation","volume":"155","author":"Di Lullo","year":"2017","journal-title":"Thromb Res"},{"issue":"8141","key":"10.1053\/j.ajkd.2020.02.446_bib6","doi-asserted-by":"crossref","first-page":"k342","DOI":"10.1136\/bmj.k342","article-title":"Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care","volume":"360","author":"Kumar","year":"2018","journal-title":"BMJ"},{"issue":"8","key":"10.1053\/j.ajkd.2020.02.446_bib7","article-title":"Novel oral anticoagulants and the risk of major hemorrhage in elderly patients with chronic kidney disease: a nested case-control study","volume":"32","author":"Harel","year":"2016","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1053\/j.ajkd.2020.02.446_bib8","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1161\/STROKEAHA.117.017549","article-title":"Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation","volume":"48","author":"Ntaios","year":"2017","journal-title":"Stroke"},{"issue":"5","key":"10.1053\/j.ajkd.2020.02.446_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/eurheartj\/ehi485","article-title":"Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25307 patients","volume":"27","author":"Andreotti","year":"2005","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1053\/j.ajkd.2020.02.446_bib10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1378\/chest.15-1719","article-title":"Stroke, major bleeding and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational studies","volume":"149","author":"Dahal","year":"2016","journal-title":"Chest"},{"issue":"11","key":"10.1053\/j.ajkd.2020.02.446_bib11","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.2215\/CJN.03200316","article-title":"Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD: con","volume":"11","author":"Keskar","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2020.02.446_bib12","first-page":"737","article-title":"Warfarin and the risk of stroke and bleeding in patients with atrial fibrillation receiving dialysis: a systematic review and meta-analysis","volume":"33","author":"Harel","year":"2017","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.02.446_bib13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.kint.2016.10.017","article-title":"The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation","volume":"91","author":"Keskar","year":"2017","journal-title":"Kidney Int"},{"issue":"16","key":"10.1053\/j.ajkd.2020.02.446_bib14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jacc.2012.02.008","article-title":"New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis\u2014Task Force on Anticoagulants in Heart Disease Position Paper","volume":"59","author":"De Caterina","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1053\/j.ajkd.2020.02.446_bib15","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1053\/j.ajkd.2020.02.446_bib16","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.jacc.2019.02.048","article-title":"Rivaroxaban plus aspirin in patients with vascular disease and renal dysfunction: from the COMPASS Trial","volume":"73","author":"Fox","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1053\/j.ajkd.2020.02.446_bib17","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehr334","article-title":"RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome","volume":"32","author":"Steg","year":"2011","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1053\/j.ajkd.2020.02.446_bib18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1105819","article-title":"Apixaban with antiplatelet therapy after acute coronary syndrome","volume":"365","author":"Alexander","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1053\/j.ajkd.2020.02.446_bib19","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1093\/eurheartj\/ehr113","article-title":"Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial","volume":"32","author":"Oldgren","year":"2011","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1053\/j.ajkd.2020.02.446_bib20","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1161\/CIRCULATIONAHA.108.832139","article-title":"Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial","volume":"119","author":"Alexander","year":"2009","journal-title":"Circulation"},{"issue":"10","key":"10.1053\/j.ajkd.2020.02.446_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"issue":"2","key":"10.1053\/j.ajkd.2020.02.446_bib23","first-page":"67","article-title":"Coding accuracy of administrative drug claims in the Ontario Drug Benefit database","volume":"10","author":"Levy","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2020.02.446_bib24","article-title":"Ontario Laboratories Information System (OLIS) \u2013 Information for providers","year":"2018","journal-title":"AOHC EMR Implementation Toolkit"},{"issue":"1","key":"10.1053\/j.ajkd.2020.02.446_bib25","first-page":"49","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"10.1053\/j.ajkd.2020.02.446_bib26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.ajkd.2020.02.446_bib27","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"1","key":"10.1053\/j.ajkd.2020.02.446_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12874-016-0119-1","article-title":"Head to head comparison of the propensity score and the high-dimensional propensity score matching methods","volume":"16","author":"Guertin","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"10.1053\/j.ajkd.2020.02.446_bib29","doi-asserted-by":"crossref","first-page":"c4226","DOI":"10.1136\/bmj.c4226","article-title":"Importance of accurately identifying disease in studies using electronic health records","volume":"341","author":"Manuel","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"10.1053\/j.ajkd.2020.02.446_bib30","doi-asserted-by":"crossref","first-page":"E413","DOI":"10.9778\/cmajo.20150060","article-title":"Validity and utility of ICD-10 administrative health data for identifying ST- and non-ST-elevation myocardial infarction based on physician chart review","volume":"3","author":"Patel","year":"2015","journal-title":"CMAJ Open"},{"issue":"3","key":"10.1053\/j.ajkd.2020.02.446_bib31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","article-title":"Use of evidence-based therapies in and short-term outcomes of STEMI and NSTEMI in patients with chronic kidney disease: a report from the National Cardiovascular Data Action Registry","volume":"121","author":"Fox","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1053\/j.ajkd.2020.02.446_bib32","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1681\/ASN.2008080860","article-title":"Prediction, progression, and outcomes of chronic kidney disease in older adults","volume":"20","author":"Anderson","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2020.02.446_bib33","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"issue":"4","key":"10.1053\/j.ajkd.2020.02.446_bib34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjcard.2013.04.011","article-title":"Comparison of the efficacy and safety of two rivaroxaban doses in acute coronary syndrome (from ATLAS ACS 2\u2013TIMI 51)","volume":"112","author":"Mega","year":"2013","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.02.446_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacc.2018.04.036","article-title":"Risk of myocardial infarction in anticoagulated patients with atrial fibrillation","volume":"72","author":"Lee","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1053\/j.ajkd.2020.02.446_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2018.03.019","article-title":"Influence of vitamin K antagonists and direct oral anticoagulation on coronary artery disease: a CTA analysis","volume":"260","author":"Plank","year":"2018","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1053\/j.ajkd.2020.02.446_bib37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ncpneph0601","article-title":"Vascular calcification in chronic kidney disease: the role of vitamin K","volume":"3","author":"Holden","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.02.446_bib38","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2215\/CJN.00770208","article-title":"Vitamin K-dependent proteins, warfarin, and vascular calcification","volume":"3","author":"Danziger","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2020.02.446_bib39","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1681\/ASN.2015050535","article-title":"The risk of major hemorrhage\u00a0with CKD","volume":"27","author":"Molnar","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.02.446_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","article-title":"Atrial fibrillation and the risk of myocardial infarction","volume":"174","author":"Soliman","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1053\/j.ajkd.2020.02.446_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/j.ajkd.2017.08.016","article-title":"Incident atrial fibrillation and the risk of congestive heart failure, myocardial infarction, end-stage kidney disease, and mortality among patients with a decreased estimated GFR","volume":"71","author":"Massicotte-Azarniouch","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2020.02.446_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijcard.2016.11.117","article-title":"Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life","volume":"227","author":"Becattini","year":"2017","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1053\/j.ajkd.2020.02.446_bib43","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/jth.13051","article-title":"Clinical impact and course of major bleeding with rivaroxaban and\u00a0vitamin K antagonists","volume":"13","author":"Eerenberg","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1053\/j.ajkd.2020.02.446_bib44","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1053\/j.ajkd.2017.07.003","article-title":"Risk of venous thromboembolism in patients by albuminuria and estimated GFR","volume":"70","author":"Massicotte-Azarniouch","year":"2017","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620306399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620306399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:29:13Z","timestamp":1759462153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638620306399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0272638620306399"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.02.446","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.02.446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}